These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21107573)
21. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation. Chen CH; Chuang HC; Huang CC; Fang FM; Huang HY; Tsai HT; Su LJ; Shiu LY; Leu S; Chien CY Am J Pathol; 2013 Feb; 182(2):516-28. PubMed ID: 23219753 [TBL] [Abstract][Full Text] [Related]
23. Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. Kamida A; Fujita Y; Kato I; Iwai S; Ono K; Suzuki M; Sakurai Y; Yura Y Int J Radiat Biol; 2008 Mar; 84(3):191-9. PubMed ID: 18300019 [TBL] [Abstract][Full Text] [Related]
24. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359 [TBL] [Abstract][Full Text] [Related]
25. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis. Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435 [TBL] [Abstract][Full Text] [Related]
26. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138 [TBL] [Abstract][Full Text] [Related]
27. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Ala-aho R; Grénman R; Seth P; Kähäri VM Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells. Zimonjic DB; Chan LN; Tripathi V; Lu J; Kwon O; Popescu NC; Lowy DR; Tamanoi F BMC Cancer; 2013 Apr; 13():198. PubMed ID: 23607551 [TBL] [Abstract][Full Text] [Related]
29. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. Fang LY; Wong TY; Chiang WF; Chen YL J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021 [TBL] [Abstract][Full Text] [Related]
30. The role of geranylgeranylated proteins in human mesangial cell proliferation. Khwaja A; Sharpe CC; Noor M; Hendry BM Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252 [TBL] [Abstract][Full Text] [Related]
31. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. Wu TT; Hsieh YH; Hsieh YS; Liu JY J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587 [TBL] [Abstract][Full Text] [Related]
32. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Kwak YE; Jeon NK; Kim J; Lee EJ Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023 [TBL] [Abstract][Full Text] [Related]
33. The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner. Vogt A; Sun J; Qian Y; Hamilton AD; Sebti SM J Biol Chem; 1997 Oct; 272(43):27224-9. PubMed ID: 9341167 [TBL] [Abstract][Full Text] [Related]
34. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA. Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases. Takayama S; Hatori M; Kurihara Y; Kinugasa Y; Shirota T; Shintani S Oncol Rep; 2009 Jan; 21(1):205-10. PubMed ID: 19082463 [TBL] [Abstract][Full Text] [Related]
36. [Mechanism of inhibiting proliferation of human ovarian cancer cells of the line HO-8910 by dexamethasone: the role of RhoB signaling pathway]. Chen YX; Li ZB; Diao F; Wang Y; Lu J Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1400-4. PubMed ID: 16796923 [TBL] [Abstract][Full Text] [Related]
37. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1. Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407 [TBL] [Abstract][Full Text] [Related]
38. [Effects of geranylgeranyltransferase Ⅰ gene silencing by RNA interference on the migration and invasion of tongue carcinoma]. Zhenggang C; Shuren W; Jinghua L; Jinhong H; Qimin W; Lei T; Wenjun L; Fang Y; Qingyuan G; Dawei G; Ying W Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Dec; 35(6):576-582. PubMed ID: 29333768 [TBL] [Abstract][Full Text] [Related]
39. RalA and RalB: antagonistic relatives in cancer cell migration. Oxford G; Owens CR; Titus BJ; Foreman TL; Herlevsen MC; Smith SC; Theodorescu D Cancer Res; 2005 Aug; 65(16):7111-20. PubMed ID: 16103060 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of geranylgeranyltransferase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production. Zuckerbraun BS; Barbato JE; Hamilton A; Sebti S; Tzeng E J Surg Res; 2005 Apr; 124(2):256-63. PubMed ID: 15820256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]